Media coverage
1
Media coverage
Title AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs Media name/outlet News-Medical.Net Country Australia Date 4/15/16 Persons Fred Poordad
Press/Media: Press / Media
Media coverage
Title | AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs |
---|---|
Media name/outlet | News-Medical.Net |
Country | Australia |
Date | 4/15/16 |
Persons | Fred Poordad |